Thoroughbred Financial Services, LLC Cel Sci Corp Transaction History

Thoroughbred Financial Services, LLC

$1.64 Billion
Q4 2024

A detailed history of Thoroughbred Financial Services, LLC transactions in Cel Sci Corp stock. As of the latest transaction made, Thoroughbred Financial Services, LLC holds 191,661 shares of CVM stock, worth $80,497. This represents 0.0% of its overall portfolio holdings.

Number of Shares

191,661

Previous 136,761 40.14%

Holding current value

$80,497

Previous $144,000 47.22%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$0.4 - $1.11 $21,960 - $60,939	54,900 Added 40.14%	191,661 $76,000
Q2 2024 Aug 08, 2024	BUY	$1.11 - $1.85 $88,801 - $148,001	80,001 Added 140.95%	136,761 $158,000
Q1 2024 May 07, 2024	SELL	$1.63 - $3.08 $114,101 - $215,603	-70,001 Reduced 55.22%	56,760 $108,000
Q4 2023 Feb 09, 2024	BUY	$1.07 - $3.07 $26,750 - $76,750	25,000 Added 24.57%	126,761 $344,000
Q3 2023 Nov 08, 2023	BUY	$1.17 - $2.86 $119,060 - $291,036	101,761 New	101,761 $127,000
Q3 2021 Oct 27, 2021	SELL	$7.64 - $12.49 $133,218 - $217,788	-17,437 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$8.68 - $27.49 $4,878 - $15,449	562 Added 3.33%	17,437 $151,000
Q1 2021 Apr 30, 2021	SELL	$12.0 - $27.64 $12,000 - $27,640	-1,000 Reduced 5.59%	16,875 $256,000
Q4 2020 Jan 26, 2021	SELL	$11.05 - $16.62 $36,907 - $55,510	-3,340 Reduced 15.74%	17,875 $208,000
Q3 2020 Oct 28, 2020	BUY	$11.69 - $14.54 $818 - $1,017	70 Added 0.33%	21,215 $270,000
Q2 2020 Jul 20, 2020	SELL	$9.75 - $17.6 $12,285 - $22,176	-1,260 Reduced 5.62%	21,145 $315,000
Q1 2020 Apr 23, 2020	SELL	$7.54 - $17.05 $54,144 - $122,436	-7,181 Reduced 24.27%	22,405 $259,000
Q4 2019 Feb 05, 2020	BUY	$6.71 - $9.55 $52,606 - $74,872	7,840 Added 36.05%	29,586 $271,000
Q3 2019 Nov 12, 2019	BUY	$6.0 - $9.6 $6,540 - $10,464	1,090 Added 5.28%	21,746 $194,000
Q2 2019 Jul 16, 2019	SELL	$3.77 - $8.67 $574,702 - $1.32 Million	-152,441 Reduced 88.07%	20,656 $0
Q2 2019 Jul 16, 2019	BUY	$3.77 - $8.67 $600,093 - $1.38 Million	159,176 Added 1143.42%	173,097 $0
Q1 2019 May 07, 2019	BUY	$2.58 - $3.54 $6,264 - $8,595	2,428 Added 21.13%	13,921 $49,000
Q4 2018 Feb 13, 2019	BUY	$2.65 - $4.26 $30,456 - $48,960	11,493 New	11,493 $32,000

Others Institutions Holding CVM

# of Institutions

Shares Held

6.98M

Call Options Held

27.1K

Put Options Held

108K

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $18.2M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thoroughbred Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thoroughbred Financial Services, LLC with notifications on news.

Account

Thoroughbred Financial Services, LLC Cel Sci Corp Transaction History